Literature DB >> 8787959

Undetectable luteinizing hormone levels using a monoclonal immunometric assay.

F Barbé1, H Legagneur, V Watrin, M Klein, Y Badonnel.   

Abstract

Previous studies have shown wide discrepancies among the results obtained with different immunometric assays. We present five cases (out of 4000 women) whose plasma luteinizing hormone was not detected using a LH immunometric assay (LH Stratus Baxter) but was recognized by other kits. These cases concerned one 28-year-old woman presenting with infertility and four postmenopausal women. The LH Amerlite kit gave detectable but low results. The results obtained with the other kits were > 7 IU/l. FSH levels were > 7 IU/l. In one case, sera were taken before and after the menopause; differences between the LH results increased. Discrepancies among LH assay kits have been attributed to variation both in standard curve calibration and in epitope specificity of the kit monoclonal antibodies. The Baxter kit might misrecognize some isoforms present in postmenopausal women. The present data illustrate the potential false results with such immunoassays in routine clinical laboratory testing. When undetectable LH results are not clinically explained or when disparities between LH and FSH are observed, we suggest using a second methodology or a bioassay if necessary. Improvement in LH assays and standardization might resolve the problem of discrepancies between the LH results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787959     DOI: 10.1007/BF03349815

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies.

Authors:  K S Pettersson; J R Söderholm
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

2.  Luteinizing hormone determinations obtained with either a monoclonal and a polyclonal antibody radioimmunoassay and their correlations with clinical findings.

Authors:  P L Venturini; V Remorgida; V Aguggia; L De Cecco
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

3.  Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin.

Authors:  K Pettersson; Y Q Ding; I Huhtaniemi
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

4.  European collaborative study of luteinizing hormone assay: 1. Epitope specificity of luteinizing hormone monoclonal antibodies and surface mapping of pituitary and urinary luteinizing hormone.

Authors:  S Costagliola; P Niccoli; M Florentino; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

5.  An immunologically anomalous luteinizing hormone variant in a healthy woman.

Authors:  K Pettersson; Y Q Ding; I Huhtaniemi
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

Review 6.  What are we measuring in gonadotropin assays?

Authors:  S L Jeffcoate
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1988

7.  Characterization of cleavage products in selected human lutropin preparations. A protease-sensitive site in human lutropin beta subunit.

Authors:  D N Ward; S D Glenn; H S Nahm; T Wen
Journal:  Int J Pept Protein Res       Date:  1986-01

8.  [Immunoassay and measurement of the biological activity of serum hLH: results obtained of a multicenter study].

Authors:  A Revol; Y Badonnel; S Carreau; M Castanier; C Collet; L Delvigne; I Denis; D Guilloteau; J P Moatti; M C Patricot
Journal:  Ann Biol Clin (Paris)       Date:  1994       Impact factor: 0.459

9.  Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard.

Authors:  I Vermes; H A Bonte; G v d Sluijs Veer; J Schoemaker
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

10.  European collaborative study on luteinizing hormone assay: 2. Discrepancy among assay kits is related to variation both in standard curve calibration and epitope specificity of kit monoclonal antibodies.

Authors:  S Costagliola; P Niccoli; M Florentino; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.